Pretreatment of rats with the selective Brd4 inhibitor NHWD-870 before the onset of ischemia considerably reduced kidney damage severity and restored nearly normal renal tissue architecture compared to renal injury severity in both the control and vehicle groups. This evidence concerns the gene BRD4 and ischemia.